Research Progress of Fucoidan in Metabolic Diseases
Metabolic diseases are diseases caused by abnormal metabolism of various nutrients in the body,including hyperlipidemia,diabetes,atherosclerosis,metabolic syndrome,hyperuricemia and other diseases.Metabolic diseases have a high incidence rate and high mortality rate from complications,making them the most concerning public health issue in the world.Fucoidan is a sulfated polysaccharide rich in fucose extracted from algae organisms,and a number of preclinical studies and clinical trials have reported that fucoidan has the effect of treating diabetes,lowering blood lipids,treating hypertension and improving obesity.This article summarizes the research progress of fucoidan in metabolic diseases and its mechanism of action in the treatment of metabolic diseases,aiming to provide reference for relevant researchers.